Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Peter Nählstedt. CEO, SenzaGen
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
SenzaGen's CEO Peter Nählstedt presents the company
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Tom Lister of Permira on Strategic Sectors, Selling Strategy, and Investor Resilience | Tom Lister, Co-Managing Partner, Permira.
00:10:00
Ceapro's patented process technologies include Pressurized Gas eXpanded technology|Gilles Gagnon,President,Ceapro Inc
00:10:00
Gato Silver's IPO and Growth Plans in Mexico's Silver and Zinc District
00:10:00
Dias Ground and Airborne Geophysical | Jonathan Rudd, P.Eng , President and Director at Dias Geophysical Limited (TS)
00:10:00
Eoin Murray: Transition from CIO at Old Mutual Asset Managers to Hedge Fund Founder
00:10:00
Fred Hu Discusses China's Economic Recovery and Future Growth Prospects | Fred Hu, CEO, Primavera Capital Group.
00:10:00
BW Epic Kosan Reports Strong Q2 and H1 2023 Results | Charles Maltby - Chief Executive Officer of BW Epic Kosan Ltd.
00:10:00
CEO Henk van Alphen Unveils Wealth Minerals' Battery Metals Projects at Deutsche Goldmesse | Henk van Alphen - CEO of Wealth Minerals Ltd.
00:10:00
Elevator Pitch: Anders Johansson, CEO of Fortinova Fastigheter | Anders Johansson, CEO, Fortinova Fastigheter AB.
00:10:00
DC Video Interview: Patrick Schorn, Borr Drilling | Patrick Schorn, CEO, Borr Drilling LtdBORR:OSL
00:10:00
Kapako Metals Explores Copper Potential at One-to-One Conference in London
00:10:00
Fundsmith CEO Terry Smith shares his approach to technology investments amid the ongoing tech sector boom with Canaccord Genuity Wealth.